Together, these data suggest that FSP1 is an NRF2 transcriptional target and that KEAP1 deficiency in lung cancer cells leads to FSP1 upregulation through NRF2, resulting in ferroptosis resistance. This evidence concerns the gene NFE2L2 and lung carcinoma.